Does BOSUTINIB Cause Hepatic cytolysis? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Hepatic cytolysis have been filed in association with BOSUTINIB (BOSULIF). This represents 0.2% of all adverse event reports for BOSUTINIB.
19
Reports of Hepatic cytolysis with BOSUTINIB
0.2%
of all BOSUTINIB reports
0
Deaths
9
Hospitalizations
How Dangerous Is Hepatic cytolysis From BOSUTINIB?
Of the 19 reports, 9 (47.4%) required hospitalization.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOSUTINIB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does BOSUTINIB Cause?
Diarrhoea (1,820)
Nausea (886)
Fatigue (626)
Vomiting (469)
Death (465)
Rash (426)
Pleural effusion (398)
Neoplasm progression (376)
Dyspnoea (319)
Headache (283)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which BOSUTINIB Alternatives Have Lower Hepatic cytolysis Risk?
BOSUTINIB vs BOTOX
BOSUTINIB vs BOTOX COSMETIC
BOSUTINIB vs BOTULINUM TOXIN NOS
BOSUTINIB vs BOTULINUM TOXIN TYPE A
BOSUTINIB vs BREMELANOTIDE